Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Your price stays the same while the same eligible plan remains active
This timeline aligns well with most vial sizes and dose levels
Repeated doses, administered weekly or biweekly, maintained IGF-1 above baseline for up to 28 days
Tirzepatide Tirzepatide acts on both GIP and GLP-1 receptors and may be prescribed instead of semaglutide, depending on the providers assessment
Wegovy is the same molecule at a higher once-weekly dose (titrated to 2.4 mg) approved for chronic weight management in obesity or overweight with a weight-related condition
The combined vial contains equal amounts of both components a format matching the most-cited research protocols in which the two peptides are administered at a 1:1 ratio
US$ 23.93
US$ 25.50
US$ 22.29
US$ 26.01
US$ 23.20
US$ 21.38
